U.S. Senate · 119th Congress · S. 5059
S. 5059
A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Ashley MoodyR-FL
- Introduced
- July 21, 2026, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (3)
2 Democrats, 1 Republican. Each member is shown with the party they were counted with on the day they signed on. How we count these